These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37720969)

  • 1. Cerebral embolic protection during transcatheter heart interventions.
    Jimenez Diaz VA; Kapadia SR; Linke A; Mylotte D; Lansky AJ; Grube E; Settergren M; Puri R
    EuroIntervention; 2023 Sep; 19(7):549-570. PubMed ID: 37720969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Difference in Post-procedural Stroke Rates Between Patients with Aortic Stenosis Who Undergo Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement.
    Burke H; Boron A; Lee JH; Kahlon KR
    Cureus; 2018 Apr; 10(4):e2494. PubMed ID: 29922535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement.
    Yashima F; Briasoulis A; Kuno T; Noguchi M; Ahmad H; Zaid S; Goldberg JB; Malik AH; Tang GHL
    Cardiovasc Revasc Med; 2022 Mar; 36():9-13. PubMed ID: 34024747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Embolic Protection Devices for Transcatheter Aortic Valve Replacement: Review of the Literature and Future Perspectives.
    Ng S; Cunningham T; Vavalle JP
    Curr Cardiol Rep; 2024 May; 26(5):339-347. PubMed ID: 38472629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological outcomes of transcatheter aortic valve implantation with or without cerebral embolic protection devices: A meta-analysis.
    Pérez-Camargo D; Travieso A; Carnero-Alcázar M; Taramasso M; Cobiella-Carnicer J; Maroto-Castellanos LC
    J Stroke Cerebrovasc Dis; 2022 Sep; 31(9):106605. PubMed ID: 35843052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
    Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
    Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a Dual-Filter Cerebral Embolic Protection Device in Thoracic Endovascular Aortic Repair.
    Shah AS; Akhmerov A; Gupta N; Chakravarty T; Makkar RR; Azizzadeh A
    Ann Vasc Surg; 2020 May; 65():54.e1-54.e4. PubMed ID: 31981683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral embolic protection in patients undergoing transcatheter aortic valve implantation: Recent advances.
    Richter I; Abdel-Wahab M; Desch S; Thiele H
    Kardiol Pol; 2022; 80(6):644-650. PubMed ID: 35521720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TriGuard
    Samim M; van der Worp B; Agostoni P; Hendrikse J; Budde RP; Nijhoff F; Ramjankhan F; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2017 Feb; 89(3):470-477. PubMed ID: 27121306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant Differences in Debris Captured by the Sentinel Dual-Filter Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Among Different Valve Types.
    Seeger J; Virmani R; Romero M; Gonska B; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1683-1693. PubMed ID: 30154060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcarotid transcatheter aortic valve replacement with cerebral embolic protection.
    McGrath D; Salehi P; Weintraub A; Zhan Y
    J Card Surg; 2022 Jun; 37(6):1779-1782. PubMed ID: 35301761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.
    Schmidt T; Leon MB; Mehran R; Kuck KH; Alu MC; Braumann RE; Kodali S; Kapadia SR; Linke A; Makkar R; Naber C; Romero ME; Virmani R; Frerker C
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1262-1273. PubMed ID: 29976363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral embolic protection devices during transcatheter aortic valve implantation, the current state of the art.
    Deveci OS; Okutucu S; Fatihoglu SG; Oto A
    Acta Cardiol; 2022 May; 77(3):196-203. PubMed ID: 33827380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embolic Protection with the TriGuard 3 System in Nonagenarian Patients Undergoing Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis.
    Lind A; Jánosi RA; Totzeck M; Ruhparwar A; Rassaf T; Al-Rashid F
    J Clin Med; 2022 Apr; 11(7):. PubMed ID: 35407611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis.
    Seeger J; Kapadia SR; Kodali S; Linke A; Wöhrle J; Haussig S; Makkar R; Mehran R; Rottbauer W; Leon M
    Eur Heart J; 2019 May; 40(17):1334-1340. PubMed ID: 30590554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral embolic protection device utilization and outcomes in transcatheter aortic valve replacement: A nationally representative propensity matched analysis.
    Altibi AM; Alhuneafat L; Jabri A; Al-Abdouh A; Ghanem F
    Cardiovasc Revasc Med; 2024 Apr; ():. PubMed ID: 38653674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: the PROTAVI-C pilot study.
    Rodés-Cabau J; Kahlert P; Neumann FJ; Schymik G; Webb JG; Amarenco P; Brott T; Garami Z; Gerosa G; Lefèvre T; Plicht B; Pocock SJ; Schlamann M; Thomas M; Diamond B; Merioua I; Beyersdorf F; Vahanian A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1146-55. PubMed ID: 25341709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.